Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
SPRY
#2141
ARS Pharmaceuticals, Inc. Common Stock
9.297
0
-1.62%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-1.62%
Variazione Mensile
-11.46%
Variazione di 6 mesi
+0.94%
Variazione Annuale
+0.94%
Chiusura Precedente
9.450
0
Open
9.280
0
Bid
Ask
Low
9.280
0
High
9.297
0
Volume
101
Mercati
Mercato Azionario Statunitense
Salute
SPRY
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
97.19 M
98.12 M
98.21 M
98.83 M
98.85 M
—
Valuation ratios
Enterprise value
1.37 B
984.35 M
1.2 B
1.67 B
933.87 M
4.79 B
Price to earnings ratio
-28.43
131.88
-78.63
-35.61
-12.41
5.23
Price to sales ratio
547.66
12.12
13.2
15.75
7.1
48.16
Price to cash flow ratio
30.42
79.73
25.46
21.24
8.75
135.18
Price to book ratio
1.6
4.21
1.38
1.97
1.21
8.76
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.09
-0.1
0.1
0.14
0.14
0.29
Return on equity %
0.1
-0.13
0.15
0.23
0.35
0.6
Return on invested capital %
—
-1 518.95
—
—
—
—
Gross margin %
100
100
100
100
100
400
Operating margin %
1 051.64
-54.51
466.29
302.95
163.66
878.38
EBITDA margin %
—
—
—
—
—
—
Net margin %
924.95
-39.2
425.69
285.57
157.38
829.44
Liquidity ratios
Quick ratio
12.52
14.04
10.74
5.69
6.24
36.7
Current ratio
12.56
14.26
11
6.17
6.66
38.09
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0.3
0.02
0.05
0.09
0.47
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
0.26
—
Long term debt to total equity ratio
—
—
—
—
0.65
—
Per share metrics
Operating cash flow per share
0.15
-0.15
0.42
0.4
0.48
1.15
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.11
3.07
2.81
2.44
2.92
11.24
Net current asset value per share
2.15
3.26
3.1
2.86
3.43
12.65
Tangible book value per share
1.99
2.44
2.26
1.82
1.35
7.87
Working capital per share
1.98
3.04
2.82
2.4
2.91
11.17
Book value per share
2.07
2.51
2.34
1.96
1.49
8.29
Notizie
ARS Pharmaceuticals Stock: Climbing Neffy Sales Global Expansion Re-Rate (NASDAQ:SPRY)
What's Going On With ARS Pharmaceuticals Stock Friday? - ARS Pharmaceuticals (NASDAQ:SPRY)
Why Is Aquestive Therapeutics Stock Falling Today? - Aquestive Therapeutics (NASDAQ:AQST)
La Cina approva il primo spray nasale di epinefrina per allergie ad uso comunitario
China approves first community use epinephrine nasal spray for allergies
Il CBO di ARS Pharma Chakma vende azioni per 1,47 milioni di dollari
Dorsey, COO di ARS Pharma, vende azioni SPRY per 190.000 dollari
ARS Pharma CBO Chakma sells shares worth $1.47 million
Dorsey, ARS Pharma COO, sells $190k in SPRY stock
ARS Pharmaceuticals, Inc. (SPRY) Q3 2025 Earnings Call Transcript
Il titolo di ARS Pharmaceuticals sale grazie alle forti vendite del Q3
ARS Pharmaceuticals: William Blair riconferma rating Outperform sui dati di neffy